Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genome-wide Epistasis for Cardiovascular Severity in Marfan Study

NCT06257004 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT06257004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genome-wide Epistasis for Cardiovascular Severity in Marfan Study
Lead sponsor
University Hospital, Antwerp
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2020
Completion date
October 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fbn1 mutation, marfan syndrome